Naso A - Search Results

1

Effect of intravenous recombinant erythropoietin administration on plasma and erythrocyte magnesium concentrations in patients on hemodialysis.

Allegra A, Corica F, Ientile R, Naso A, Corsonello A, Montalto G, Castagna L, Buemi M. Allegra A, et al. Among authors: naso a. Nephron. 1996;74(2):499-500. doi: 10.1159/000189414. Nephron. 1996. PMID: 8893212 Free article. No abstract available.

2

Nitric oxide synthase in chick embryo retina during development.

Ientile R, Malecka B, Picciurro V, Naso A, Pedale S, Macaione S. Ientile R, et al. Among authors: naso a. FEBS Lett. 1996 Jan 22;379(1):82-4. doi: 10.1016/0014-5793(95)01490-x. FEBS Lett. 1996. PMID: 8566236 Free article.

3

Hypoprothrombinemia and cephalosporins in uremia. Part II.

Vertolli U, Vinci C, Naso A. Vertolli U, et al. Among authors: naso a. Nephron. 1995;69(1):111. doi: 10.1159/000188381. Nephron. 1995. PMID: 7891784 Free article. No abstract available.

4

Hypoprothrombinemia and cephalosporins in uremics.

Vertolli U, Vinci C, Naso A. Vertolli U, et al. Among authors: naso a. Nephron. 1992;62(2):239. doi: 10.1159/000187046. Nephron. 1992. PMID: 1436326 Free article. No abstract available.

5

Hemodiafiltration with online regeneration of ultrafiltrate: effect on heme-oxygenase-1 and inducible subunit of nitric oxide synthase and implication for oxidative stress and inflammation.

Calò LA, Naso A, Davis PA, Pagnin E, Corradini R, Tommasi A, Sereni L, Ragazzi E. Calò LA, et al. Among authors: naso a. Artif Organs. 2011 Feb;35(2):183-7. doi: 10.1111/j.1525-1594.2010.01045.x. Epub 2010 Oct 14. Artif Organs. 2011. PMID: 20946294

6

Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis.

Cella G, Vertolli U, Naso A, Vianello A, Rampin E, Sbarai A, Boeri G, Strauss WE. Cella G, et al. Among authors: naso a. Thromb Res. 1996 Mar 15;81(6):671-7. doi: 10.1016/0049-3848(96)00044-8. Thromb Res. 1996. PMID: 8868518

7

Clinical effects of a low protein diet supplemented with essential amino acids and keto analogues in uremic patients.

Di Landro D, Perin N, Bertoli M, Gasparotto ML, Ruffatti A, Naso A, Vertolli U, Urso M, Romagnoli GF. Di Landro D, et al. Among authors: naso a. Contrib Nephrol. 1986;53:137-43. doi: 10.1159/000413157. Contrib Nephrol. 1986. PMID: 3802820 No abstract available.

8

A Very Unique Case of Boric Acid Intoxication With Very High-magnitude Rhabdomyolysis.

Vertolli U, Alessi M, Naso E, Naso A, Calò LA. Vertolli U, et al. Among authors: naso a. Iran J Kidney Dis. 2017 May;11(3):256-257. Iran J Kidney Dis. 2017. PMID: 28575889 Free article. No abstract available.

9

Eccentric LVH healing after starting renal replacement therapy.

Vertolli U, Lupia M, Naso A. Vertolli U, et al. Among authors: naso a. J Nephrol. 2002 Jul-Aug;15(4):403-5. J Nephrol. 2002. PMID: 12243371

10

"Of coronary arteries and men": the fight of a dialysis patient against his coronary arteries.

Vertolli U, Vinci C, Rebeschini M, Ruffatti A, Scaparrotta G, Napodano M, Naso A, Calò LA. Vertolli U, et al. Among authors: naso a. Ren Fail. 2014 May;36(4):627-30. doi: 10.3109/0886022X.2014.882239. Epub 2014 Feb 6. Ren Fail. 2014. PMID: 24502603 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters